• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II RING; ANNULOPLASTY RING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II RING; ANNULOPLASTY RING Back to Search Results
Model Number 5200M
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Coagulation Disorder (1779); Mitral Regurgitation (1964); Mitral Valve Stenosis (1965); Regurgitation, Valvular (2335)
Event Date 06/21/2019
Event Type  malfunction  
Manufacturer Narrative
Udi number: (b)(4).The device was not returned for the evaluation; therefore, no conclusion can be made as the cause of the reported event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.In this case, edwards implant patient registry received information a 32mm annuloplasty ring was explanted after an implant duration of 15 days due to mitral stenosis and regurgitation.The explanted device was replaced with a 29mm mitral valve.There was no evidence of any perivalvular leak.The patient also underwent tricuspid valve replacement with a 31mm edwards mitral tissue valve during the procedure.Once the patient was off bypass there was significant coagulopathy and two blood products were used.
 
Manufacturer Narrative
The device was not returned to edwards for evaluation as it was reported to have not been received by hospital pathology.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.The causes of re-operation for a failed annuloplasty repairs are well documented in the literature.Re-operations are primarily the result of a progression of disease or technical failures and are not related to product malfunctions.Unlike prosthetic heart valves, annuloplasty rings are an adjunct to the valve repair.Based on the information received the cause cannot be conclusively determined; however, patient factors likely contributed to the event.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PHYSIO II RING
Type of Device
ANNULOPLASTY RING
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key8819480
MDR Text Key154111651
Report Number2015691-2019-02738
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
PMA/PMN Number
K083470
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 06/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/26/2023
Device Model Number5200M
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/28/2019
Initial Date FDA Received07/23/2019
Supplement Dates Manufacturer Received07/29/2019
07/23/2020
Supplement Dates FDA Received08/11/2019
12/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age75 YR
-
-